Million in Biological Technology

DOE awards $377 million in funding for 46 energy frontier research centers

Washington, DC In a major effort to accelerate the scientific breakthroughs needed to build a new 21st-century energy economy, U.S. Energy Secretary Steven Chu announced the delivery of $377 million in funding for 46 new multi-million-dollar Energy Frontier Research Centers (EFRCs) located at uni...

Onyx Pharmaceuticals Announces Pricing of Concurrent Offerings of Four Million Shares of Common Stock and $200 Million Principal Amount of Convertible Senior Notes

EMERYVILLE, Calif., Aug. 6 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that it has agreed to sell an aggregate of four million shares of its common stock at a price to the public of $30.50 per share and $200 million aggregate principal amou...

The Law Offices of Brian D. Witzer Wins 6+ Million Dollar Verdict

LOS ANGELES, Aug. 6 /PRNewswire/ -- A jury in Pasadena, California awarded over $6 million to an 82 year-old Chinese female immigrant who suffered Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis after taking the drug Allopurinol. She alleged that the Defendant, an osteopathic p...

Micromet Closes $80.5 Million Public Offering of Common Stock

BETHESDA, Md., Aug. 4, /PRNewswire-FirstCall/ --Micromet, Inc. (Nasdaq: MITI ) ("Micromet" or the "Company"), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced the closing of its previ...

Oramed Pharmaceuticals was Awarded a NIS 3.1 Million Grant From the Israeli Office of the Chief Scientist

JERUSALEM, Israel, August 4 /PRNewswire-FirstCall/ -- Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) ( http://www.oramed.com ), a developer of oral delivery systems, today reported that its wholly owned Israeli subsidiary, Oramed Ltd., was awarded a government grant amounting to a total net amo...

W.M. Keck Foundation Awards $1 Million to Hutchinson Center Scholar to Study How Cells Go Awry

SEATTLE, Aug. 3 /PRNewswire/ -- Anyone touched by the ravages of cancer knows the rapidly growing, opportunistic cells don't play fair. But in order to expose exactly how cancer cells cheat their host, scientists must first study the rules governing the orderly cooperation of normal cell...

PharmAthene, Inc. Closes on $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants

ANNAPOLIS, Md., July 31 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, today announced that, effective July 28, 2009, it has closed on the issuance of 2-year, 10% unsecured ...

PROLOR Biotech Announces $10 Million Preferred Stock Line From Members of The Frost Group

NES-ZIONA, Israel, July 24 /PRNewswire-FirstCall/ -- PROLOR Biotech, Inc. (OTC Bulletin Board: PBTH), formerly Modigene Inc., today announced that it has entered into stock purchase agreements with private investors to sell up to $10 million of the company's newl...

OncoGenex Pharmaceuticals Completes $9.5 Million Registered Direct Offering

BOTHELL, WA and VANCOUVER, July 24 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI ) announced today that it has completed its registered direct offering, previously announced on July 20, 2009, of 475,000 shares of its common stock to institutional investors at a price of ...

Response Genetics Announces $4 Million Private Placement

LOS ANGELES, July 22 /PRNewswire-FirstCall/ -- Response Genetics, Inc. (Nasdaq: RGDX ) announced today that it has entered into a purchase agreement with certain funds managed by Lansdowne Partners Limited Partnership to raise approximately $4 million from the private placeme...

KTA Capital Advises SpringTree Global Investors on an AU$25.5 Million Investment in Prima BioMed Ltd

SpringTree Special Opportunities Fund, LP ("SpringTree") announced today its AU$25,500,000 investment in Prima BioMed Ltd (ASX:PRR), an Australian Securities Exchange-listed oncology biotechnology company. KTA Capital acted as the exclusive financial advisor to SpringTree's general part...

NewLink Genetics Corporation Closes $7.5 Million Financing

AMES, Iowa, July 20 /PRNewswire/ -- NewLink Genetics Corporation announced today that it has secured $7.5 million in a Series D financing to accelerate the clinical development of its therapeutic cancer products. This financing involved additional funding from prior investors. ...

OncoGenex Pharmaceuticals to Raise $9.5 Million Through Sale of Common Stock

BOTHELL, WA and VANCOUVER, July 20 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI ) announced today it has entered into purchase agreements with certain institutional investors for the sale of 475,000 shares of its common stock at a price of $20 per share through a regist...

Nile Therapeutics, Inc. Completes $3.4 Million Private Placement

SAN FRANCISCO, July 16 /PRNewswire-FirstCall/ -- Nile Therapeutics, Inc. (Nasdaq: NLTX ), a company focused on the development of novel therapeutics for heart failure patients, today announced that it has completed a private placement of shares of its common stock and warrants to purchase a...

Novavax Announces Repayment of $5 Million of Convertible Debt

ROCKVILLE, Md., July 15 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX ) today announced that it has repaid the remaining $5.0 million balance of its convertible notes. These convertible notes carried a coupon rate of 4.75% payable semi-annually and had a maturity date of July ...

Accuri Cytometers Completes $4 Million Series D Financing

ANN ARBOR, Mich., July 13 /PRNewswire/ -- Accuri Cytometers, Inc. today announced the completion of a $4 million Series D financing. The financing included current investors Fidelity Biosciences, Flagship Ventures, Baird Venture Partners and Arboretum Ventures, as well as the InvestMichigan! Prog...

Viral Genetics Retires Nearly $3.5 Million Convertible Debt and Provides Updates on Capital Structure and Stock Issuances

SAN MARINO, Calif., July 13 /PRNewswire-FirstCall/ -- Viral Genetics (Pink Sheets: VRAL), a biotechnology company that develops drug compounds for HIV/AIDS, autoimmune diseases, and cancer, has retired the majority of its $3.5 million of convertible debt. The company also retired other ...

Senesco Technologies Enters Into Agreement For Up To $1.0 Million In Financing

NEW BRUNSWICK, N.J., July 10 /PRNewswire-FirstCall/ -- Senesco Technologies , Inc. ("Senesco" or the "Company") (NYSE Amex: SNT ) today announced that, on July 9, 2009, the Company entered into a definitive purchase agreement with Partlet Holdings Ltd. for the issuance and sale of (i) up to 1...

OncologyRx Care Advantage(TM) Specialty Pharmacy Passes $15 Million Milestone in Patient Financial Assistance

THE WOODLANDS, Texas, July 9 /PRNewswire/ -- US Oncology, Inc . today announced that OncologyRx Care Advantage(TM) , its national oral oncology specialty pharmacy service, has exceeded the $15 million mark and has assisted more than 3,300 patients in obtaining external support for drug co-...

Intellikine Completes $51 Million Financing

LA JOLLA, Calif., July 8 /PRNewswire/ -- Intellikine, Inc., a leader in the development of innovative, small molecule drugs for the treatment of cancer, inflammation and autoimmune diseases, announced today that it has raised $51 million in preferred stock financing. Novartis Bioventures Ltd. led...

Nile Therapeutics, Inc. To Raise $3.4 Million in Private Placement

SAN FRANCISCO, July 8 /PRNewswire-FirstCall/ -- Nile Therapeutics, Inc. (Nasdaq: NLTX ), a company focused on the development of novel therapeutics for heart failure patients, today announced that it has received commitments from investors to purchase in a private placement securities of the Com...

Cord Blood America Secured $7.5 Million Investment For Series A Preferred Stock

SANTA MONICA, Calif., July 7 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), one of the largest umbilical cord blood stem cell preservation companies ( http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells to families nati...

Gyros Raises SEK 80 Million to Accelerate the Commercialization of its Gyrolab(R) Systems for the Cost-Efficient Development of Biopharmaceuticals

UPPSALA, Sweden, June 29 /PRNewswire/ -- - Financing Led by SLS Invest Will Fund Gyros to Profitability Gyros AB, the leading provider of automated micro-immunoassays for therapeutic protein development, announces that it has raised SEK 80 million (approximately euro 7.5 million)...

Television News Segment Featuring Pyratine XR to Air to 18 Million + Households on DIRECTV NewsCluster

- Bloomberg and CNN among stations to run 30-second spot on Pyratine XR(TM) and Rosacea - NAPA, Calif., June 26 /PRNewswire-FirstCall/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, annou...

Clavis Pharma Raises NOK 129 Million (USD 20 Million) in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug Candidates

OSLO, Norway, June 26 /PRNewswire-FirstCall/ -- Clavis Pharma ASA (OSE: CLAVIS) today announced that the Company has raised NOK 129 million (equivalent to USD 20 million) in gross proceeds through a private placement of 10,750,000 new shares, each with a par value of NOK 1.00 at a price of NOK...

AEterna Zentaris Receives US$10 Million from Institutional Investors

QUEBEC CITY, June 24 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS ; TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and oncology, announced today that it has completed its previously announced registered direct offering of US$10 million of units compris...

CEL-SCI Signs Definitive Agreement to Raise $5 Million in Registered Direct Offering

VIENNA, Va., June 24 /PRNewswire-FirstCall/ -- CEL-SCI Corporation (NYSE AMEX: CVM ) , a late stage cancer immunotherapy company, today announced that it has entered into a definitive agreement with one institutional investor to sell 12.5 million units, with each unit consisting of one of the...

Syngenta Issues EUR 500 Million Eurobond

BASEL, Switzerland, June 23 /PRNewswire-FirstCall/ -- Syngenta announced today the successful issue of a EUR 500 million Eurobond with a five year maturity. The proceeds of the bond will be used for general funding purposes. John Ramsay, CFO, said: "We have taken advantage of favorable curren...

PTC Therapeutics Receives $2.6 Million in Government Grants

- Funding supports continued focus on rare disorders - SOUTH PLAINFIELD, N.J., June 15 /PRNewswire/ -- PTC Therapeutics, Inc. (PTC) today announced the receipt of two government grants to support clinical development programs in rare disorders. The U.S. Department of Defense Neurofibromatosi...

Cappella Inc. Secures $17.3 Million Series C Investment

- New and existing investors complete a $17.3 million Series C investment - Experienced medical device executive, Dr. Art Rosenthal, appointed as CEO - Aggressive launch of Sideguard(TM) Sidebranch stent in EU following recent CE Marking - Expansion of management team, R&D and m...

China Biologic Products Closes the $9.6 Million Private Placement

TAI'AN CITY, China, June 11 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that on June 10, 2009, th...

Providence Health & Services Increases Revenue by $35 Million Using Concuity ClearContracts

Providence expands use of Concuity products across 16 facilities following success to date increasing net revenue VERNON HILLS, Ill., June 8 /PRNewswire-FirstCall/ -- Concuity, A Healthcare Division of Trintech, Inc. (Nasdaq: TTPA ) announced today that Providence Health & Service...

Pharmaxis Announces Placement of $47 Million and Share Purchase Plan

SYDNEY, June 3 /PRNewswire-Asia/ -- Pharmaxis (ASX: PXS, Nasdaq: PXSL ) today announced that it had raised A$47 million through a placement to Australian and international institutions and professional investors. The placement strengthens the company's balance sheet as Pharmaxis moves towar...

Cell Therapeutics Amends and Restates Its 'Modified Dutch Auction' Tender Offer to a Fixed Price Tender Offer for Any and All of Its $118.9 Million Outstanding Convertible Notes

SEATTLE, June 2 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (the "Company" or "CTI") (Nasdaq and MTA: CTIC) today announced that it has amended and restated its "Modified Dutch Auction" tender offer to a fixed price tender offer for any and all of the approximately $118.9 million outstanding...

GenVec Announces Registered Offering of $6 Million in Common Stock and Warrants

GAITHERSBURG, Md., May 28 /PRNewswire-FirstCall/ -- GenVec, Inc. (Nasdaq: GNVC ) announced today that it has entered into a purchase agreement with a single institutional investor for the sale of 9,615,385 shares of its common stock and warrants to purchase 9,615,385 shares of its common stock...

Oncothyreon announces closing of $11.1 million registered direct financing

SEATTLE, May 27 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY ) (TSX: ONY) announced today that it closed its previously announced sale of 3,878,993 shares of its common stock and warrants to purchase 2,909,244 shares of its common stock for gross proceeds of approximately $11.1 millio...

Cord Blood America Says Debt Reduced $4.194 Million in 2009

SANTA MONICA, Calif., May 27 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company ( http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells to families nationwide and inter...

Cephalon Prices 5 Million Shares of Common Stock and $435 Million in 2.50% Convertible Senior Subordinated Notes in Public Offerings

FRAZER, Pa., May 21 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH ) announced today the pricing of its concurrent public offerings of 5 million shares of common stock, at a price of $60 per share, and $435 million in aggregate principal amount of 2.50% convertible senior subordinated no...

Oncothyreon announces commitments to purchase $11.1 million of company securities in a registered direct financing

SEATTLE, May 20 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY ) (TSX: ONY) announced today that it has obtained commitments from several investors to purchase approximately 3.88 million shares of its common stock and warrants to purchase approximately 2.91 million shares of its common ...

Cell Therapeutics Amends 'Modified Dutch Auction' Tender Offer for up to $89.2 million of Its Outstanding Convertible Notes

SEATTLE, May 18 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (the "Company" or "CTI") (Nasdaq and MTA: CTIC) today announced that it has amended its "Modified Dutch Auction" tender offer (the "Exchange Offer") to increase the total consideration of its offer to exchange shares of its common s...